首页> 外文期刊>纳米研究(英文版) >Antarctic thermolabi le uracil--DNA--glycosylase-·rnsupplemented multiple cross displacement amplificationrnusing a label·-based nanoparticle lateral flow biosensorrnfor the simultaneous detection of nucleic acid sequencesrnand el i mi nation of carryover contam i nation
【24h】

Antarctic thermolabi le uracil--DNA--glycosylase-·rnsupplemented multiple cross displacement amplificationrnusing a label·-based nanoparticle lateral flow biosensorrnfor the simultaneous detection of nucleic acid sequencesrnand el i mi nation of carryover contam i nation

机译:南极热尿嘧啶-DNA-糖基化酶-辅助基于标记的纳米颗粒侧向流生物传感器的多重交叉位移扩增,用于同时检测核酸序列和残留物污染

获取原文
获取原文并翻译 | 示例
       

摘要

Here, we report a novel and universal methodology, termed "Antarctic thermolabile uracil-DNA-glycosylase (AUDG)-supplemented nucleic acid amplification techniques (NAAs) using a labeled-based nanoparticle lateral flow biosensor (LFB)" (AUDG-NAAs-LFB), which merges enzymatic (AUDG) digestion of contaminant amplicons with different nucleic acid amplification techniques (NAAs), and uses a lateral flow biosensor (LFB) for the rapid and visual confirmation of the presence of a target nucleic acid sequence. AUDG-NNAs-LFB is a one-pot, closed-vessel assay, that can effectively eliminate false-positive signals arising from either carryover contaminants or the interaction between labeled primers. A new LFB was devised for detecting three targets (two amplicons generated from amplification of target sequences, and a chromatography control), without the need for probe-hybridization or additional incubation steps. As a proof of concept, multiple cross displacement amplification (MCDA), which is a specific, sensitive, and rapid isothermal amplification method, was selected as the model amplification technique to demonstrate the feasibility of AUDG-NAAs-LFB. As a result, we demonstrate the applicability of the AUDG-MCDA-LFB method for simultaneously detecting high-risk human papillomaviruses genotypes 16 and 18, which are the most and second-most prevalent strains of the virus reported in women worldwide. We also confirm the principle behind the AUDG-MCDA-LFB assay and validate its sensitivity, reproducibility, and specificity using serial dilutions of the type-specific plasmids, as well as clinical samples. This proof-of-concept method (AUDG-MCDA-LFB) can be easily reconfigured to detect various nucleic acid sequences by redesigning the specific MCDA primers.
机译:在这里,我们报告了一种新颖的通用方法,称为“使用基于标记的纳米颗粒侧向流动生物传感器(LFB)的南极不耐热尿嘧啶DNA-糖基化酶(AUDG)-补充的核酸扩增技术(NAA)”(AUDG-NAAs-LFB ),将污染物扩增子的酶促(AUDG)消化与不同的核酸扩增技术(NAA)合并在一起,并使用侧向流生物传感器(LFB)快速和目视确认目标核酸序列的存在。 AUDG-NNAs-LFB是一种单罐封闭容器测定法,可以有效消除残留污染物或标记引物之间相互作用产生的假阳性信号。设计了一种新的LFB,无需检测探针杂交或其他孵育步骤即可检测三个靶标(通过扩增靶标序列和色谱控制获得两个扩增子)。作为概念验证,选择了一种特定,灵敏且快速的等温扩增方法的多重交叉位移扩增(MCDA)作为模型扩增技术,以证明AUDG-NAAs-LFB的可行性。结果,我们证明了AUDG-MCDA-LFB方法可同时检测高风险的人类乳头瘤病毒基因型16和18,这是全世界女性中报告的该病毒的最高和第二高流行株。我们还确认了AUDG-MCDA-LFB分析背后的原理,并使用类型特异性质粒和临床样品的系列稀释液验证了其灵敏度,可重复性和特异性。通过重新设计特定的MCDA引物,可以轻松地重新配置此概念验证方法(AUDG-MCDA-LFB)以检测各种核酸序列。

著录项

  • 来源
    《纳米研究(英文版)》 |2018年第5期|2632-2647|共16页
  • 作者单位

    State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing 102206, China;

    Department of Microbiology, Guizhou Medical University, Guiyang 550004, China;

    State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing 102206, China;

    The Sixth People's Hospital of Zhengzhou, Zhengzhou450000, China;

    State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing 102206, China;

    State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing 102206, China;

  • 收录信息 中国科学引文数据库(CSCD);中国科技论文与引文数据库(CSTPCD);
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 03:47:26
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号